Editorial

From the desk of the editor

Welcome to the May 2012 homepage edition of i2P-Information to Pharmacists. Rollo Manning has been having some time out having staples removed from the site of his open heart surgery.He is now at home recuperating in Darwin, having arrived home last Friday, beating a cold and hasty retreat from Canberra.We all wish him a speedy recovery and hopefully, he will be fit enough to contribute by next month.
This month, Pharmedia discusses the toll that is taken when someone complains about you to an authority without good cause. Well, the good news is that you can now take action to protect yourself if such a complaint is made, and that may even include action for defamation. Read about a recent case involving two doctors, with Mark Coleman drawing on personal experience to illustrate.

read more
open full screen

Columns

Recent Comments

Click here to read...

Past Editions

Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4

i2P Archives

EPublications

Click here for a list of epublications

ASMI Media Releases April 2012

• Printer-friendly version
• Send to friend
• PDF version
• Share

	Bob Bowden articles by this author...
Information and news from the Australian Self Medication Industry provided by Bob Bowden, Foresight Communications. Contact him on (02) 9241 2811 or 0412 753 298.

Information and news from the Australian Self Medication Industry provided by Bob Bowden, Foresight Communications.
Contact him on(02) 9241 281 or 0412 753 298 .

open this article full screen

24 April 2012

ASMI welcomes consultation on next step to strengthen complementary medicines regulation

 The Australian Self-Medication Industry (ASMI), the industry body representing evidence based nonprescription consumer healthcare products today welcomed steps by the Therapeutic Goods Administration (TGA) to strengthen the regulation of complementary medicines (CMs).

The TGA has issued a draft discussion paper, Evidence required to support indications for listed medicines’, which outlines the nature of evidence required to support health claims made for CMs.

Specifically, the document is aimed at clarifying requirements for sponsors and improving the Australian community’s understanding of the TGA’s regulatory processes and decisions and enhancing public trust in the safety and quality of therapeutic goods.

The document specifies the type of evidence required to support indications made for listed (low risk) medicines and is intended to replace the ‘Guidelines for Levels and Kinds of Evidence to Support Indications and Claims for

Non-Registerable Medicines, including Complementary Medicines and other Listable Medicines’.

The TGA intends to embed the document within the legislative framework for regulation of therapeutic goods in Australia. This reflects a recommendation of the Working Group on Complementary Medicines, a group made up of industry and stakeholders who have been lobbying for more rigor in the Complementary Medicines regulatory framework. It was also agreed to inprinciple by the Government in TGA Reforms: A blueprint for TGA’s future.

The Executive Director of ASMI, Dr Deon Schoombie, said the release of the draft paper should set the tone for a thorough examination of the way that complementary medicines are positioned in th Australian market.

 “If consumers are to have faith in the rapidly growing complementary medicines industry, there needs to be a high level of confidence, rigour and transparency around the way that complementary medicines are marketed, including the health claims that are made about individual products.

“ASMI has long argued for appropriate regulation of the sector, with more accurate and timely advice to the public that helps to protect the credibility of those products that are proven and evidence-based.

__________________________________________________________________

About ASMI: The Australian Self-Medication Industry (ASMI) is the peak industry body for the Australian self care industry representing consumer healthcare products including over-the-counter medicines and complementary medicines. ASMI’s mission is to promote better health through responsible self-care. This means ensuring that safe and effective self-care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective selfmedication products as part of the broad national health strategy.www.asmi.com.au

Media contact: Bob Bowden, Foresight Communications (02) 9241 2811, 0412 753 298

Clinical Newsfeed

Click here to read more...

Research Reports

Practice Development

Information Technology

Preventive Medicine

i2P Alliance Partners